Stay updated with breaking news from Antisense Oligonucleotide. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DelveInsight's, Encephalopathy Pipeline Insight 2024 report provides comprehensive insights about 70+ Encephalopathy companies and 70+ pipeline drugs in the Encephalopathy pipeline landscape. It...
Novo Nordisk’s strategy to grow beyond metabolic diseases includes expanding into adjacent areas such as cardiovascular disease. Acquiring Cardio Pharmaceuticals adds a novel RNA-based therapy that is a potential heart failure treatment.
-- ACADIA Pharmaceuticals has an average rating of outperform and price targets ranging from $13 to $40, according to analysts polled by Capital IQ. Price: 19.98, Change: -4.15, Percent Change:...
-- ACADIA Pharmaceuticals has an average outperform rating and a price target range of $13 to $40, according to analysts polled by Capital IQ. Price: 19.21, Change: -4.92, Percent Change: -20.39 ...
AstraZeneca's Wainua receives FDA approval in the US